Literature DB >> 17546678

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease.

Chiara Balducci1, Laura Pierguidi2,3, Emanuele Persichetti1, Lucilla Parnetti2, Michele Sbaragli1, Carmelo Tassi4, Aldo Orlacchio4, Paolo Calabresi2,3, Tommaso Beccari1, Aroldo Rossi2.   

Abstract

Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of beta-glucocerebrosidase and the activities of other lysosomal enzymes, alpha-mannosidase, beta-mannosidase, beta-hexosaminidase, and beta-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of alpha-mannosidase, beta-mannosidase, beta-glucocerebrosidase, and beta-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of beta-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases. Copyright 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546678     DOI: 10.1002/mds.21399

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  54 in total

1.  GBA mutations in Parkinson disease: earlier death but similar neuropathological features.

Authors:  C H Adler; T G Beach; H A Shill; J N Caviness; E Driver-Dunckley; M N Sabbagh; A Patel; L I Sue; G Serrano; S A Jacobson; K Davis; C M Belden; B N Dugger; S A Paciga; A R Winslow; W D Hirst; J G Hentz
Journal:  Eur J Neurol       Date:  2017-08-17       Impact factor: 6.089

2.  Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies.

Authors:  S Pablo Sardi; Jennifer Clarke; Catherine Viel; Monyrath Chan; Thomas J Tamsett; Christopher M Treleaven; Jie Bu; Lindsay Sweet; Marco A Passini; James C Dodge; W Haung Yu; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

Review 3.  Cerebrospinal fluid biomarkers in Parkinson disease.

Authors:  Lucilla Parnetti; Anna Castrioto; Davide Chiasserini; Emanuele Persichetti; Nicola Tambasco; Omar El-Agnaf; Paolo Calabresi
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

Review 4.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

Review 5.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

6.  cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Authors:  Philipp Spitzer; Hans Wolfgang Klafki; Kaj Blennow; Luc Buée; Hermann Esselmann; Sanna-Kaisa Herruka; Connie Jimenez; Peter Klivenyi; Piotr Lewczuk; Juan Manuel Maler; Katrin Markus; Helmut E Meyer; Chris Morris; Thorsten Müller; Markus Otto; Lucilla Parnetti; Hilkka Soininen; Susanna Schraen; Charlotte Teunissen; Laszlo Vecsei; Henrik Zetterberg; Jens Wiltfang
Journal:  Int J Alzheimers Dis       Date:  2010-09-19

Review 7.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

8.  Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.

Authors:  Patrick J Schultheis; Sheila M Fleming; Amy K Clippinger; Jada Lewis; Taiji Tsunemi; Benoit Giasson; Dennis W Dickson; Joseph R Mazzulli; Mark E Bardgett; Kristi L Haik; Osunde Ekhator; Anil Kumar Chava; John Howard; Matt Gannon; Elizabeth Hoffman; Yinhuai Chen; Vikram Prasad; Stephen C Linn; Rafael J Tamargo; Wendy Westbroek; Ellen Sidransky; Dimitri Krainc; Gary E Shull
Journal:  Hum Mol Genet       Date:  2013-02-07       Impact factor: 6.150

Review 9.  The association between ß-glucocerebrosidase mutations and parkinsonism.

Authors:  Matthew Swan; Rachel Saunders-Pullman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

10.  The expanding role of genetics in the lewy body diseases: the glucocerebrosidase gene.

Authors:  James B Leverenz; Oscar L Lopez; Steven T Dekosky
Journal:  Arch Neurol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.